| Pseudomonas aeruginosa and microbial keratitis Y Hilliam, S Kaye, C Winstanley Journal of medical microbiology 69 (1), 3-13, 2020 | 142 | 2020 |
| Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung Y Hilliam, MP Moore, IL Lamont, D Bilton, CS Haworth, J Foweraker, ... European Respiratory Journal 49 (4), 2017 | 94 | 2017 |
| Microbial and Immune Regulation of the Gut-Lung Axis during Viral-Bacterial Coinfection S Lane, Y Hilliam, JM Bomberger Journal of Bacteriology 205 (1), e00295-22, 2023 | 5 | 2023 |
| Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis SE Atteih, CR Armbruster, Y Hilliam, GJ Rapsinski, JK Bhusal, LL Krainz, ... Pediatric Pulmonology 59 (5), 1266-1273, 2024 | 4 | 2024 |
| Elexacaftor–tezacaftor–ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis AC Zemke, Y Hilliam, AL Stapleton, AJ Kimple, JL Goralski, AD Shaffer, ... International Forum of Allergy & Rhinology 14 (5), 928-938, 2024 | 3 | 2024 |
| Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis CR Armbruster, YK Hilliam, AC Zemke, S Atteih, CW Marshall, J Moore, ... Mbio 15 (5), e00519-24, 2024 | 2 | 2024 |
| Pseudomonas aeruginosa diversity and adaptation in the non-cystic fibrosis bronchiectasis lung Y Hilliam, M Moore, I Lamont, CS Haworth, J Foweraker, D Bilton, ... Pneumologie 70 (10), A18, 2016 | 1 | 2016 |
| LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients C Winstanley, Y Hilliam, M Moore, I Lamont, C Haworth, D Bilton, ... European Respiratory Journal 48 (suppl 60), 2016 | 1 | 2016 |
| 1 Pseudomonas aeruginosa-phage interactions are influenced by polymicrobial biofilms P Zamora, Y Hilliam, R Martin, J Bomberger Journal of Cystic Fibrosis 23, S1, 2024 | | 2024 |
| 17 In vitro modeling of polymicrobial airway infections accurately represents gene expression of Pseudomonas aeruginosa in chronic cystic fibrosis infection Y Hilliam, R Martin, L Michaels, J Shimkonis, F Jean-Pierre, A Kapur, ... Journal of Cystic Fibrosis 23, S9, 2024 | | 2024 |
| Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy Y Hilliam, CR Armbruster, GJ Rapsinski, CW Marshall, J Moore, J Koirala, ... Microbiology Spectrum 12 (8), e00787-24, 2024 | | 2024 |
| 53 Persistence and evolution of Pseudomonas aeruginosa after initiation of highly effective modulator therapy in cystic fibrosis C Armbruster, Y Hilliam, A Zemke, S Atteih, C Marshall, J Moore, J Koirala, ... Journal of Cystic Fibrosis 22, S29, 2023 | | 2023 |
| 90 Initiation of elexacaftor-tezacaftor-ivacaftor treatment lowers total bacterial load in airways but does not increase microbial diversity or lead to eradication of known … Y Hilliam, C Armbruster, A Zemke, S Atteih, C Marshall, J Moore, J Koirala, ... Journal of Cystic Fibrosis 22, S47, 2023 | | 2023 |
| 540 Developing a murine model for lung infection in cystic fibrosis that reflects Pseudomonas aeruginosa infection dynamics in the cystic fibrosis lung R Duncan, D Moustafa, G Lewin, D Cornforth, F Diggle, A Kapur, Y Hilliam, ... Journal of Cystic Fibrosis 21, S301, 2022 | | 2022 |
| 477 Longitudinal population genetics of Pseudomonas aeruginosa isolated from the sinuses, throat, and sputum of adults with cystic fibrosis C Armbruster, Y Hilliam, S Attieh, A Zemke, C Marshall, J Moore, J Melvin, ... Journal of Cystic Fibrosis 21, S271-S272, 2022 | | 2022 |
| 464 Impact of elexacaftor/tezacaftor/ivacaftor on the sinonasal microbiome A Zemke, A Stapleton, A Kimple, J Goralski, Y Hilliam, S Amber, J Pilewski, ... Journal of Cystic Fibrosis 21, S265-S266, 2022 | | 2022 |
| Resistance and tolerance of Pseudomonas aeruginosa to contact lens disinfection solutions Y Hilliam University of Liverpool, 2020 | | 2020 |
| Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients YK Hilliam, A Perry, AJ Hall, J Davison, KE Walton, J Fothergill, ... European Respiratory Journal 46 (suppl 59), 2015 | | 2015 |
| Genotyping of Pseudomonas aeruginosa isolates from pulmonary infections in non-cystic fibrosis bronchiectasis patients Y Hilliam PQDT-Global, 2015 | | 2015 |
| Pseudomonas aeruginosa adaptation and diversification in the non-Cystic Fibrosis Y Hilliam, MP Moore, IL Lamont, D Bilton, CS Haworth, J Foweraker, ... genome 726 (328), 7, 0 | | |
Craig WinstanleyUniversity of Liverpool在 liv.ac.uk 的电子邮件经过验证
